Baker Ellis Asset Management’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
Other funds holding SNY
MIP
BIP
Baker Ellis Asset Management's SNY Position: Q2 2026 in Review
Baker Ellis Asset Management reduced its Sanofi (SNY) stake by 2.1% in Q2 2026, selling an estimated $77.1K and leaving 81,342 shares worth $3.47M. The position accounts for 0.36% of the portfolio, ranked #65.
Baker Ellis Asset Management first reported a position in SNY in Q2 2014 and has held it in 21 quarters since. The position peaked at $5.44M in Q3 2023. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- Baker Ellis Asset Management held 81,342 shares of Sanofi worth $3.47M as of Q2 2026.
- Baker Ellis Asset Management sold 1,725 Sanofi shares in Q2 2026, an estimated $77.1K.
- Sanofi made up 0.36% of Baker Ellis Asset Management's portfolio in Q2 2026, its #65 holding.
- Baker Ellis Asset Management first reported a position in Sanofi in Q2 2014 and has held it in 21 quarters since.
- Baker Ellis Asset Management's Sanofi position peaked at $5.44M in Q3 2023.
- 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on Baker Ellis Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.